Literature DB >> 29235676

Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis.

Masatoshi Jinnin1, Toshiyuki Yamamoto2, Yoshihide Asano3, Osamu Ishikawa4, Shinichi Sato3, Kazuhiko Takehara5, Minoru Hasegawa6, Manabu Fujimoto7, Hironobu Ihn1.   

Abstract

We established diagnostic criteria and severity classification of eosinophilic fasciitis because there is no established diagnostic criteria or widely accepted severity classification of the disease. Also, there has been no clinical guideline for eosinophilic fasciitis, so we established its clinical guideline ahead of all over the world. In particular, the clinical guideline was established by clinical questions based on evidence-based medicine according to the New Minds Clinical Practice Guideline Creation Manual (version 1.0). We aimed to make the guideline easy to use and reliable based on the newest evidence, and to present guidance as specific as possible for various clinical problems in treatment of eosinophilic fasciitis.
© 2017 Japanese Dermatological Association.

Entities:  

Keywords:  collagen; eosinophils; fibrosis; guideline; skin

Mesh:

Substances:

Year:  2017        PMID: 29235676     DOI: 10.1111/1346-8138.14160

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  11 in total

1.  Atypical Presenting Symptoms of Acute Onset Acquired Haemophilia with Eosinophilic Fasciitis.

Authors:  Yuto Nakakubo; Kazuyo Yamamoto; Masaaki Fujita
Journal:  Eur J Case Rep Intern Med       Date:  2020-06-15

2.  [Imaging of eosinophilic fasciitis in ultrasound and MRI (magnetic resonance imaging): a case report].

Authors:  Nicolas Gerritzen; Jana Ziob; Peter Brossart; Valentin S Schäfer
Journal:  Z Rheumatol       Date:  2022-05-16       Impact factor: 1.372

3.  Eosinophilic Fasciitis and Smoldering Multiple Myeloma: An Exceptional Association in Young Adults.

Authors:  Rajaa Jabbouri; Nouama Bouanani; Rita Aniq Filali; Jehanne Aasfara
Journal:  Cureus       Date:  2022-04-06

4.  Eosinophilic fasciitis in a pregnant woman with corticosteroid dependence and good response to infliximab.

Authors:  Nicolás Jiménez-García; Josefa Aguilar-García; Inés Fernández-Canedo; Nuria Blázquez-Sánchez; Rafael Fúnez-Liébana; Carlos Romero-Gómez
Journal:  Rheumatol Int       Date:  2021-01-23       Impact factor: 2.631

5.  UVA-1 phototherapy as adjuvant treatment for eosinophilic fasciitis: in vitro and in vivo functional characterization.

Authors:  Linda Tognetti; Camilla Marrocco; Andrea Carraro; Edoardo Conticini; Cyril Habougit; Giancarlo Mariotti; Elisa Cinotti; Jean Luc Perrot; Pietro Rubegni
Journal:  Int J Dermatol       Date:  2021-12-08       Impact factor: 3.204

6.  Eosinophilic Fasciitis of Wrists with a Positive Prayer Sign.

Authors:  Xia Li; Zhen Tian; Fang Kong; Yi Zhao; Xiaoxia Li
Journal:  Cureus       Date:  2020-01-07

7.  Eosinophilic Fasciitis - Report of Three Cases and Review of the Literature.

Authors:  Uwe Wollina; Gesina Hansel; Jacqueline Schönlebe; Birgit Heinig; Ivanka Temelkova; Georgi Tchernev; Aleksandra Vojvocic; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2019-05-15

8.  Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced "Eosinophilic Fasciitis-Like" Case and a Review of the Literature.

Authors:  Christina Salamaliki; Elena E Solomou; Stamatis-Nick C Liossis
Journal:  Rheumatol Ther       Date:  2020-10-16

9.  Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab.

Authors:  Evangelia Zampeli; Eleftherios Zervas
Journal:  Mediterr J Rheumatol       Date:  2021-12-27

10.  Proton Pump Inhibitor and Tacrolimus Uses are Associated With Hypomagnesemia in Connective Tissue Disease: a Potential Link With Renal Dysfunction and Recurrent Infection.

Authors:  Hironari Hanaoka; Jun Kikuchi; Yuko Kaneko; Noriyasu Seki; Hideto Tsujimoto; Kenji Chiba; Tsutomu Takeuchi
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.